We postulated, however, that such maximally synergistic danger signals might safely and conveniently be applied to unfractionated PBMC outside the body in order to strongly activate innate immunity, license acquired immunity, and ramp up in vitro sensitization of natural T-cells, both CD4+ and CD8+, to tumor-associated antigens. The gene discussed is CD8A; the disease is neoplasm.